Tempus AI Net Change in Intangible Assets 2023-2025 | TEM

Tempus AI annual/quarterly net change in intangible assets history and growth rate from 2023 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
  • Tempus AI net change in intangible assets for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
  • Tempus AI net change in intangible assets for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
  • Tempus AI annual net change in intangible assets for 2024 was $0B, a 0% decline from 2023.
  • Tempus AI annual net change in intangible assets for 2023 was $0B, a 0% decline from 2022.
  • Tempus AI annual net change in intangible assets for 2022 was $0B, a 0% decline from .
Tempus AI Annual Net Change in Intangible Assets
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $13.255B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.824B 59.57
Doximity (DOCS) United States $12.564B 55.90
Hims & Hers Health (HIMS) United States $10.250B 83.98
IRhythm Technologies (IRTC) United States $5.398B 0.00
Hinge Health (HNGE) United States $4.325B 0.00
Inspire Medical Systems (INSP) United States $2.713B 39.89
Privia Health (PRVA) United States $2.625B 194.46
Heartflow (HTFL) $2.547B 0.00
Phreesia (PHR) United States $1.833B 0.00
Enovis (ENOV) United States $1.782B 9.42
10x Genomics (TXG) United States $1.747B 0.00
Omnicell (OMCL) United States $1.503B 28.96
Schrodinger (SDGR) United States $1.446B 0.00
Azenta (AZTA) United States $1.401B 61.14
Clover Health Investments (CLOV) United States $1.368B 0.00
Claritev (CTEV) United States $1.196B 0.00
Evolent Health (EVH) United States $1.089B 0.00
Fulgent Genetics (FLGT) United States $0.657B 0.00
Zepp Health (ZEPP) Netherlands $0.585B 0.00
Veradigm (MDRX) United States $0.536B 0.00
Standard BioTools (LAB) United States $0.493B 0.00
Talkspace (TALK) United States $0.447B 133.50
Butterfly Network (BFLY) United States $0.400B 0.00
Carlsmed (CARL) United States $0.365B 0.00
TruBridge (TBRG) United States $0.300B 52.66
Outset Medical (OM) United States $0.251B 0.00
Health Catalyst (HCAT) United States $0.246B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.228B 0.00
Nyxoah SA (NYXH) Belgium $0.218B 0.00
KORU Medical Systems (KRMD) United States $0.197B 0.00
CapsoVision (CV) United States $0.184B 0.00
MDxHealth SA (MDXH) Belgium $0.171B 0.00
CareCloud (CCLD) United States $0.156B 7.08
ImmunoPrecise Antibodies (IPA) Canada $0.127B 0.00
American Well (AMWL) United States $0.113B 0.00
EUDA Health Holdings (EUDA) Singapore $0.084B 0.00
Pulmonx (LUNG) United States $0.072B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.039B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Precipio (PRPO) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
PROFUSA (PFSA) United States $0.014B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00